Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04169841
Title Study Evaluating the Efficacy of a Double Immunotherapy Combined With Olaparib in Patients With Solid Cancers and Carriers of Homologous Recombination Repair Genes After Olaparib Treatment (GUIDE2REPAIR)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Centre Georges Francois Leclerc
Indications

endometrial cancer

clear cell renal cell carcinoma

ovarian cancer

lung cancer

breast cancer

prostate cancer

head and neck cancer

transitional cell carcinoma

Therapies

Durvalumab + Olaparib + Tremelimumab

Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
CHU Amiens Not yet recruiting Amiens France Details
CHRU Jean Minjoz Not yet recruiting Besançon France Details
Institut Bergonié Recruiting Bordeaux France Details
Centre Georges François Leclerc Recruiting Dijon 21000 France Details
CHU François Mitterrand Recruiting Dijon France Details
Institut Hospitalier Franco-Britannique Not yet recruiting Levallois-Perret France Details
Centre Oscar Lambret Recruiting Lille France Details
Centre Leon Berard Not yet recruiting Lyon France Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field